Andrew Rezvani
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant (NCT03267186) | Andrew Rezvani | 2017-09-12 |
Track Andrew Rezvani automatically
Every clearance here is in the API, with alerts when new ones post.